SAMHPSDC: Screening and Management of High-risk Populations of Stroke in Dehui City

Sponsor
Yi Yang (Other)
Overall Status
Completed
CT.gov ID
NCT05039034
Collaborator
Dehui People's Hospital (Other)
4,100
1
14.9
274.3

Study Details

Study Description

Brief Summary

This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.

Condition or Disease Intervention/Treatment Phase
  • Other: Advice according to primary prevention guidelines on stroke of China

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
4100 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Screening and Management of High-risk Populations of Stroke in Dehui City
Actual Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Mar 31, 2016
Actual Study Completion Date :
Mar 31, 2017

Arms and Interventions

Arm Intervention/Treatment
Low-risk Group

Low-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).

Other: Advice according to primary prevention guidelines on stroke of China

Mediate-risk Group

Mediate-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).

Other: Advice according to primary prevention guidelines on stroke of China

High-risk Group

High-risk Group is defined as the population with ≥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack.

Other: Advice according to primary prevention guidelines on stroke of China

Outcome Measures

Primary Outcome Measures

  1. Prevalence rate of stroke [4 months]

    The proportion of stroke in the general population.

  2. Prevalence rate of hypertension [4 months]

    The proportion of hypertension in the general population.

  3. Prevalence rate of diabetes mellitus [4 months]

    The proportion of diabetes mellitus in the general population.

  4. Prevalence rate of dyslipidemia [4 months]

    The proportion of dyslipidemia in the general population.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged 40 years and over in Dehui City

  • Willing to participate in the study and follow-up visits

  • Signed an informed consent

Exclusion Criteria:
  • Life expectancy<3 years

  • Unwilling to participate in the study and follow-up visits

  • Living away from Dehui City over 6 months

  • Unable to cooperate with examination and questionnaire due to mental disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Hospital of Jilin University Changchun Jilin China 130000

Sponsors and Collaborators

  • Yi Yang
  • Dehui People's Hospital

Investigators

  • Study Chair: Yi Yang, M.D. Ph.D., The First Hospital of Jilin University
  • Study Director: Ying-Qi Xing, M.D. Ph.D., The First Hospital of Jilin University
  • Study Director: Zhen-Ni Guo, M.D., The First Hospital of Jilin University
  • Principal Investigator: Fu-Liang Zhang, M.D., The First Hospital of Jilin University
  • Principal Investigator: Hao-Yuan Liu, M.D., The First Hospital of Jilin University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yi Yang, Associated Dean of First Hospital of Jilin University, The First Hospital of Jilin University
ClinicalTrials.gov Identifier:
NCT05039034
Other Study ID Numbers:
  • SMDC
First Posted:
Sep 9, 2021
Last Update Posted:
Sep 9, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Yi Yang, Associated Dean of First Hospital of Jilin University, The First Hospital of Jilin University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 9, 2021